<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Anakinra, una alternativa potencial en el tratamiento de la infecci√≥n respiratoria grave por SARS-CoV-2 refractaria a tocilizumab</article-title>
 <trans-title-group xml:lang="en">
  <trans-title>Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab</trans-title>
 </trans-title-group>
</title-group>
